Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.70M P/E - EPS this Y - Ern Qtrly Grth -
Income -723.5M Forward P/E - EPS next Y - 50D Avg Chg -71.00%
Sales 2.21B PEG - EPS past 5Y 2.23% 200D Avg Chg -85.00%
Dividend N/A Price/Book 0.01 EPS next 5Y -11.70% 52W High Chg -94.00%
Recommedations 3.00 Quick Ratio 0.94 Shares Outstanding 84.73M 52W Low Chg 1,900.00%
Insider Own 11.20% ROA 0.77% Shares Float 78.63M Beta 2.82
Inst Own 0.41% ROE -108.59% Shares Shorted/Prior 41.72M/42.05M Price 0.02
Gross Margin 40.37% Profit Margin -32.48% Avg. Volume 361,659 Target Price -
Oper. Margin 5.22% Earnings Date Apr 20 Volume 290,539 Change 0.00%
About Mallinckrodt plc

Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, pulmonology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes; and gastrointestinal products. It offers Acthar Gel, a repository corticotropin injection for rheumatoid arthritis, infantile spasms, systemic lupus erythematosus, multiple sclerosis, systemic dermatomyositis, symptomatic sarcoidosis, severe acute and chronic allergic, and inflammatory diseases; INOmax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Therakos photopheresis, an immunotherapy treatment platform; Amitiza for constipation; and StrataGraft for the treatment of adults with deep partial-thickness burns. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; and SLN 501 is a ribonucleic acid silencing therap. In addition, it provides specialty generic drugs and active pharmaceutical ingredients. The company markets its branded products to physicians, respiratory therapists, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with Silence Therapeutics plc to develop and commercialize ribonucleic acid interference drug targets. The company was founded in 1867 and is based in Dublin, Ireland. On October 12, 2020, Mallinckrodt plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

MNKKQ Chatroom

User Image 11thestate Posted - 1 week ago

$MNKKQ Mallinckrodt Paying to Investors Over Its Achtar Scandal: https://www.reddit.com/r/biotech_stocks/comments/1e6j0e1/mallinckrodt_paying_to_investors_over_its_achtar/

User Image DonCorleone77 Posted - 10/27/24

$MNKTQ $MNKKQ Mallinckrodt presents data on TERLIVAZ for injection in patients with HRS Mallinckrodt announced a poster presentation on TERLIVAZ for injection in patients with hepatorenal syndrome with rapid reduction in kidney function at Kidney Week 2024, the annual meeting of the American Society of Nephrology taking place in San Diego from October 23-27, 2024. The poster presentation highlights a pooled analysis of data from the CONFIRM and REVERSE Phase 3 placebo-controlled trials of TERLIVAZ.5 The analysis examined the rates of hepatorenal syndrome-acute kidney injury reversal, renal replacement therapy, and liver transplant among a subpopulation of patients listed for LT at baseline who met FDA label guidelines for treatment with TERLIVAZ. In this patient subpopulation, treatment with TERLIVAZ increased the rate of HRS-AKI reversal and reduced the need for RRT at all time points assessed. The increase in HRS-AKI reversal with TERLIVAZ did not negatively impact the LT rate in patients listed for LT at baseline. The rate of HRS-AKI reversal was 43% in the TERLIVAZ group and 20% in the placebo group. The rate of RRT in the TERLIVAZ and placebo groups was 28% and 46% by Day 30; 32% and 54% by Day 60; and 36% and 54% by Day 90, respectively. The LT rate was similar in the TERLIVAZ and placebo groups at all time points assessed: 53% and 51% by Day 30; 66% and 57% by Day 60; and 66% and 63% by Day 90, respectively. The limitations of this study include, but are not limited to, small sample sizes, variables in methodology, and possible errors and omissions within the data sets.

User Image 11thestate Posted - 09/24/24

$MNKKQ agreed to a $46M settlement with $MNKKQ investors regarding the safety and viability of its drug Acthar for ALS treatment. If you bought $MNKKQ between May 03, 2016, and March 18, 2020, you can file for payment here: https://11thestate.com/cases/mallinckrodt-investor-settlement

User Image 11thestate Posted - 08/29/24

$MNKKQ is accepting claims for a $67.75M settlement it is paying to investors over deceiving investors about sales in 2015-2017 years. Even if the filing deadline has passed, if you bought between October 06, 2015 and November 06, 2017, you can still check details and get your payment here: https://11thestate.com/cases/313

User Image 11thestate Posted - 07/29/24

$MNKKQ has reached an agreement with $MNKKQ investors to settle claims that its drug Acthar was unsafe for ALS treatment and that Mallinckrodt overstated its viability. You can check if you are eligible and file for the payment here: https://11thestate.com/cases/mallinckrodt-investor-settlement

User Image 11thestate Posted - 07/18/24

$MNKKQ has reached an agreement with $MNKKQ investors to settle claims that its drug Acthar was unsafe for ALS treatment and that Mallinckrodt overstated its viability. You can check if you are eligible and file for the payment here: https://11thestate.com/cases/mallinckrodt-investor-settlement

User Image navnilak Posted - 6 months ago

$MNKKQ scammers

User Image Little_Brother Posted - 02/20/24

$MNKKQ this POS is the scam of the century. They fleeced the retail investor twice in 3 years.

User Image BuBleRunner Posted - 11 months ago

$LKNCY $blue $TRIRF $MNKKQ $ENDPQ

User Image fin_researcher Posted - 11 months ago

⚠️#SEC dropped a $40M penalty against $MNK for overcharging #Medicaid. ~ The decision factored in $MNKKQ financial condition and was contingent on the company retaining a compliance consultant. https://11thestate.com/cases/mallinckrodt-investor-lawsuit

User Image fin_researcher Posted - 11/29/23

$MNKKQ lawsuit was filed and you can check and join it here: https://11thestate.com/cases/mallinckrodt-investor-lawsuit Mallinckrodt failed to pay interest payments on bonds and disclosed that may need to file for bankruptcy. $MNKKQ share price fell 30%+ Investors suspect Mallinckrodt & its Leaders of misleading & financial misrepresentation.

User Image EarningsInsider Posted - 11/22/23

Mallinckrodt plc Files SEC Form 3 $MNKKQ https://www.marketbeat.com/stocks/OTCMKTS/MNKKQ/sec-filings/

User Image EarningsInsider Posted - 11 months ago

Mallinckrodt plc Files SEC Form 3 $MNKKQ https://www.marketbeat.com/stocks/OTCMKTS/MNKKQ/sec-filings/

User Image EarningsInsider Posted - 1 year ago

Mallinckrodt plc Files SEC Form 8-K $MNKKQ https://www.marketbeat.com/stocks/OTCMKTS/MNKKQ/sec-filings/

User Image fin_researcher Posted - 1 year ago

Investors who faced losses because of the $MNKKQ stock drop could join lawsuit to recover their investments https://11thestate.com/cases/mallinckrodt-investor-lawsuit

User Image fbats Posted - 1 year ago

$MNKKQ https://www.ft.com/content/35b6ea14-5d0f-4fbb-bec2-cc157cd0e7e6

User Image i_like_them_parabolic Posted - 09/20/23

$MNKKQ is it available for sell?

User Image NorrisChuck Posted - 08/29/23

$MNKKQ May every debtor associated with this company burn in hell

User Image Scrotie__Mcboogerballs Posted - 08/29/23

@RealGameTheory how many shares outstanding on $MNKKQ were there before their double whammy double bankruptcy yesterday? Why did they go bankrupt twice when they had $400mm on their balance sheet and way less liabilities known and unknown????????

User Image Scrotie__Mcboogerballs Posted - 08/29/23

$AMC Wen Citadel flavor popcorn? Hey crayon eaters, Cool G and duh moon gang, I have a good idea, let’s all buy bankrupt companies like $RADCQ $YELLQ $MNKKQ $AMC and become moon boys and hate on the GOAT 🐐 Kenneth Cordel Griffin because he’s getting more Bugattis and ChoCha in Miami with his beautiful piercing blue eyes than us. Wen Chapter 69? Isda Phase 69 already passed. Where’s my lambo and AMC credit card?

User Image EarningsInsider Posted - 08/29/23

Mallinckrodt plc Files SEC Form 8-K $MNKKQ https://www.marketbeat.com/stocks/OTCMKTS/MNKKQ/sec-filings/

User Image Nith414 Posted - 08/28/23

$MNKTQ it’s now $MNKTQKQ

User Image EarningsInsider Posted - 08/28/23

Mallinckrodt plc Files SEC Form 8-K $MNKKQ https://www.marketbeat.com/stocks/OTCMKTS/MNKKQ/sec-filings/

User Image EarningsInsider Posted - 08/23/23

Mallinckrodt plc Files SEC Form 8-K $MNKKQ https://www.marketbeat.com/stocks/OTCMKTS/MNKKQ/sec-filings/

User Image EarningsInsider Posted - 1 year ago

Mallinckrodt plc Files SEC Form 8-K $MNKKQ https://www.marketbeat.com/stocks/OTCMKTS/MNKKQ/sec-filings/

User Image EarningsInsider Posted - 1 year ago

Mallinckrodt plc Files SEC Form 10-Q $MNKKQ https://www.marketbeat.com/stocks/OTCMKTS/MNKKQ/sec-filings/

User Image EarningsInsider Posted - 1 year ago

Mallinckrodt plc Files SEC Form 8-K $MNKKQ https://www.marketbeat.com/stocks/OTCMKTS/MNKKQ/sec-filings/

User Image GABBYGIRL Posted - 07/31/23

$MNKKQ shortsxare panicking.

User Image Bewater85 Posted - 07/27/23

$MNKKQ wow

User Image Bewater85 Posted - 07/27/23

$MNKKQ down or up ?

Analyst Ratings
SVB Leerink Market Perform Sep 14, 20
Citigroup Sell Aug 6, 20
JP Morgan Underweight May 19, 20
SVB Leerink Market Perform May 6, 20
Barclays Equal-Weight Apr 2, 20
CFRA Hold Apr 1, 20
B of A Securities Underperform Feb 26, 20
Stifel Hold Sep 9, 19
BMO Capital Market Perform Sep 5, 19